IMMUNE AND CYTOKINE STATUS IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING ALEMTUZUMAB

In present work, we studied cytokine levels and performed analysis of some immunologic parameters in the patients with chronic lymphocytic leukemia (CLL) before and after treatment with monoclonal anti-CD52 antibody (alemtuzumab). In comparison with a control group, the CLL patients before alemtuzum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: M. N Khorobrykh, T. P. Zagoskina, V. I. Shardakov, E. L. Nazarova, A. V. Yovdiy
Formato: Artigo
Idioma:Russo
Publicado em: SPb RAACI 2014-07-01
Colecção:Medicinskaâ Immunologiâ
Assuntos:
chronic lymphocytic leukemia
cytokines
lymphocyte subsets
alemtuzumab
cd52
Acesso em linha:https://www.mimmun.ru/mimmun/article/view/408
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados